UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Details
Sales, net	$ 12,572	$ 10,479	$ 36,140	$ 30,168
Cost of goods sold	4,499	3,982	13,336	11,885
Gross profit	8,073	6,497	22,804	18,283
Operating expense
Selling, general and administrative	2,848	2,785	8,669	8,480
Research & development	127	125	385	375
Total operating expenses	2,975	2,910	9,054	8,855
Operating income	5,098	3,587	13,750	9,428
Other income	59	1	130	125
Income before provision for income taxes	5,157	3,588	13,880	9,553
Provision for income taxes	951	655	3,224	2,167
Net income	$ 4,206	$ 2,933	$ 10,656	$ 7,386
Earnings per common share (basic)	$ 1.15	$ 0.81	$ 2.92	$ 2.02
Earnings per common share (diluted)	$ 1.15	$ 0.80	$ 2.91	$ 2.01
Shares outstanding - basic	3,647	3,642	3,645	3,664
Shares outstanding - diluted	3,658	3,653	3,656	3,678
Other comprehensive income (loss):
Foreign currency translation net of taxes of $0 in all periods	$ (782)	$ 1,511	$ (787)	$ (416)
Total comprehensive income	$ 3,424	$ 4,444	$ 9,869	$ 6,970